Suchergebnisse

National Vision (EYE) came out with quarterly earnings of $0.25 per share, beating the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.18 per share a year ago. These

Amcor (AMCR) came out with quarterly earnings of $1.23 per share, beating the Zacks Consensus Estimate of $1.18 per share. This compares to earnings of $1 per share a year ago. These figures are

Any investors hoping to find a Sector - Other fund could think about starting with Fidelity Select Retailing (FSRPX). FSRPX carries a Zacks Mutual Fund Rank of 1 (Strong Buy), which is based on

There is never a wrong time to invest in mutual funds for retirement. So, if you're still looking for the best mutual funds, the Zacks Mutual Fund Rank can be a great guide.

The easiest, most

TELUS Corporation TU shares have fallen 22% in the past three months as investors absorb a sharp reset in earnings, cash flow and operating expectations. The pullback has pushed valuation close to a

Belite Bio BLTE announced that the FDA has accepted the new drug application (NDA) seeking approval for its lead candidate, tinlarebant, for the treatment of patients with Stargardt Disease type I

F.N.B. Corporation FNB is accelerating its push into higher-margin wealth management businesses as it seeks to expand recurring fee income and deepen relationships with ultra-high-net-worth

Murphy USA Inc. MUSA combines strong earnings momentum, favorable fuel economics and a growing store base. The Zacks Consensus Estimate calls for 2026 earnings of $36.53 per share versus $24.10 in

TELUS Corporation TU is trading at a valuation discount while its core connectivity and health assets continue to generate cash. That gives value-focused investors a reason to look closer.

The

Madison Square Garden Entertainment (MSGE) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.42. This compares to a loss of $0.5 per share a year

Tandem Diabetes Care, Inc. TNDM reported a second-quarter 2026 loss of 31 cents per share, narrower than the Zacks Consensus Estimate of a loss of 34 cents. The figure improved from the year-ago

For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and

For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and

Milestone Pharmaceuticals (MIST) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to a loss of $0.2 per share a year ago. These

Radcom (RDCM) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of $0.2. This compares to earnings of $0.25 per share a year ago. These figures are adjusted for

Marex Group PLC (MRX) came out with quarterly earnings of $1.64 per share, beating the Zacks Consensus Estimate of $1.36 per share. This compares to earnings of $1.02 per share a year ago. These

Kamada (KMDA) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.13 per share a year ago. These figures are

Kornit Digital (KRNT) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of a loss of $0.02 per share. This compares to earnings of $0.03 per share a year ago

Aurora Cannabis ACB suddenly became one of the hottest names in the marijuana space on Tuesday, following an unsolicited takeover approach from Curaleaf Holdings CURLF.

Curaleaf announced its

Fidelity Blue Chip Growth Fund FBGRX and Fidelity Growth Company Fund FDGRX, two of Fidelity’s Large Cap Growth mutual fund offerings, have delivered strong gains in 2026, helped in part by their